https://en.wikipedia.org/wiki/Microneedles

Microneedling has gained popularity in medical aesthetics and drug delivery due to its minimally invasive, painless, and highly effective nature. However, this does not mean it is a flawless, risk-free technique. Any procedure that penetrates the skin barrier, no matter how minor, may carry certain side effects. A proper understanding of these side effects and their underlying mechanisms is essential for both industry professionals and consumers to make informed decisions.

The most common side effect after microneedling is localized skin reaction. Since microneedling creates dozens to hundreds of microscopic channels in the stratum corneum, the skin initiates an acute inflammatory response as a defense mechanism. Typical symptoms include erythema, mild swelling, and a burning sensation that appear immediately after treatment, resembling mild sunburn. These symptoms usually peak within 30 minutes to 2 hours after the procedure and then gradually subside. For standard cosmetic microneedling with needle lengths between 200 and 500 micrometers, erythema typically resolves completely within 24 to 48 hours. However, when deeper treatments are performed using devices with needle lengths exceeding 500 micrometers, erythema may persist for up to 3 to 5 days.

Although pain and discomfort are milder than with traditional injections, they are not entirely absent. During microneedling, some patients may still experience slight stinging or tingling sensations, especially in areas with thinner skin such as around the eyes and lips. For individuals with a lower pain threshold, this discomfort may be more pronounced. Additionally, the type of microneedling device can influence the level of discomfort-electric microneedle pens typically have higher vibration frequencies and are generally more comfortable than manual roller devices; hollow microneedles, which require injection of medication, may cause additional pressure or swelling-related pain.

Hyperpigmentation is another side effect worth noting. In individuals with darker skin tones (Fitzpatrick types IV to VI), microneedling may trigger post-inflammatory hyperpigmentation. This occurs because the microtrauma induced by microneedling activates melanocytes, leading to excessive local pigment deposition. Data indicate that the incidence of post-microneedling hyperpigmentation in Asian populations is approximately 2% to 5%, commonly associated with excessive treatment pressure, inappropriate needle length selection, or inadequate sun protection after treatment. In contrast, hypopigmentation is relatively rare but occasionally observed in areas subjected to repeated treatments.

Although the risk of infection is low, it does exist. Microneedling disrupts the skin barrier, theoretically creating an entry point for bacteria. If the procedure is performed in a non-sterile environment, instruments are inadequately sterilized, or post-treatment care is improper, Staphylococcus aureus or Propionibacterium acnes may invade, leading to folliculitis, pustules, or even cellulitis. A retrospective study indicated that the infection rate following microneedling at accredited medical institutions is less than 0.1%, whereas in beauty salons or self-administered home treatments, the rate can rise to 1%–3%.

Allergic reactions are also a type of side effect that cannot be overlooked. Microneedling is often combined with functional ingredients such as vitamin C, hyaluronic acid, and botulinum toxin. The microchannels created by microneedling significantly enhance the transdermal absorption of these substances, but they also increase the risk of allergen exposure. For patients known to be allergic to certain components, microneedling delivery may trigger more severe contact dermatitis than topical application alone.

Understanding the mechanisms behind these side effects is not intended to undermine the value of microneedling, but rather to establish a scientific framework for risk management. Only with full informed consent can both physicians and patients collaboratively develop the optimal treatment plan.